Nurse-led Proactive Telephone Follow-up With Patients After Completion of Primary Cancer Treatment

U

Umeå University

Status

Enrolling

Conditions

Breast Cancer
Prostate Cancer
Colorectal Cancer

Treatments

Behavioral: Proactive nurse-led telephone follow-up

Study type

Interventional

Funder types

Other

Identifiers

NCT06223022
Department of Nursing

Details and patient eligibility

About

The goal of this randomized study is to test and evaluate nurse-led telephone follow-up intervention in patients primarily curatively treated for breast cancer, colorectal cancer, and prostate cancer. The main question aims to answer: Does this nurse-led telephone follow-up improve patients' quality of life? Participants in both groups will be asked to fill in questionnaires regularly. The intervention group will get a telephone follow-up at predetermined intervals, while the control group will get the care as usual.The investigators will compare intervention and control groups to see if predetermined regular nurse-led telephone follow-up improves quality of life.

Full description

The hypothesis is that nurse-led telephone follow-up will improve the quality of life in patients primarily curatively treated for breast cancer, colorectal cancer, and prostate cancer. Participants in both groups will respond to a survey regularly during one year from inclusion. The intervention group will get a telephone follow-up at predetermined intervals (1, 3, 6, 9, 12 months) while the control group will get the care as usual. The usual care means that no proactive support is offered to patients from health care while they wait for follow-up, but patients are of course allowed to contact health care if they needed. Participants in both groups are asked to respond on a survey concerning their quality of life, feelings of anxiety and depression, perception of illness, and experienced symptoms and discomfort regarding to cancer. Additionally, the number of visits at the health care during the waiting for follow-up will be collected from both group.

Enrollment

512 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Being primarily curatively treated for breast, colorectal-, or prostate cancer

Exclusion criteria

  • no adjuvant treatment
  • no cognitive impairment
  • no known alcohol or other misuse

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

512 participants in 2 patient groups

Intervention
Experimental group
Description:
Receiving regular telephone nurse-led support
Treatment:
Behavioral: Proactive nurse-led telephone follow-up
Control
No Intervention group
Description:
Receiving care as usual

Trial contacts and locations

1

Loading...

Central trial contact

Sonja Marklund, RN; Senada Hajdarevic, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems